Retour sur lavenir.net
   UCB 259.200 € (-5,71 %)     WDP 21.960 € (-0,90 %)     D'IETEREN GROUP 170.800 € (+0,77 %)     TUBIZE-FIN 227.000 € (-6,12 %)     COLRUYT 34.620 € (-2,70 %)     AB INBEV 70.760 € (-0,73 %)     XIOR 26.400 € (-0,94 %)     AEDIFICA 70.050 € (-1,06 %)     SYENSQO 67.500 € (+1,66 %)     UMICORE 23.500 € (+3,80 %)     JENSEN-GROUP 84.000 € (-0,47 %)     ECONOCOM GROUP 1.555 € (+0,97 %)     SHURGARD 23.950 € (-0,42 %)     KBC ANCORA 79.900 € (+1,01 %)     MONTEA 66.700 € (-0,45 %)     SIPEF 93.000 € (-0,53 %)     VGP 83.300 € (+1,83 %)     TINC 11.820 € (-0,34 %)     RETAIL ESTATES 70.000 € (-1,13 %)     AGEAS 67.050 € (+0,68 %)     BPOST 1.674 € (-1,53 %)     IMMOBEL 21.500 € (+3,37 %)     FAGRON 24.350 € (-1,62 %)     ONTEX GROUP 2.460 € (-0,20 %)     EVS 30.150 € (+0,50 %)     WERELDHAVE BELGIUM 52.000 € (-1,14 %)     VIOHALCO 19.980 € (+4,72 %)     CARE PROPERTY INV. 12.400 € (+0,16 %)     FLUXYS BELGIUM D 19.750 € (-1,25 %)     OPTION 7.200 € (+20,00 %)     ARGENX SE 761.200 € (-2,86 %)     ATENOR 1.650 € (-2,94 %)     KBC 115.500 € (+0,79 %)     TITAN S.A. 53.300 € (+2,30 %)     BARCO 8.630 € (+0,76 %)     ELIA GROUP 133.900 € (-1,47 %)     SOLVAY 27.200 € (+1,49 %)     PROXIMUS 6.500 € (-0,46 %)     MELEXIS 82.350 € (+2,17 %)     BEKAERT 42.450 € (+3,03 %)     ASCENCIO 53.300 € (+1,52 %)     CIE BOIS SAUVAGE 309.000 € (-0,32 %)     RECTICEL 10.760 € (+0,56 %)     COFINIMMO 82.300 € (-0,96 %)     DECEUNINCK 2.290 € (+0,66 %)     CMB.TECH 13.340 € (+0,15 %)     GIMV 45.750 € (+0,77 %)     IBA 16.200 € (-2,76 %)     BREDERODE 103.800 € (+0,78 %)     NYXOAH 1.400 € (-0,43 %)     TESSENDERLO 20.450 € (+0,49 %)     AGFA-GEVAERT 0.426 € (+0,71 %)     BIOTALYS 3.215 € (+1,74 %)     KINEPOLIS GROUP 33.850 € (+1,65 %)     GBL 80.850 € (+0,56 %)     NEXTENSA 46.800 € (-2,01 %)     ACKERMANS V.HAAREN 282.000 € (+0,71 %)     ENERGYVISION 14.400 € (-0,69 %)     ONWARD MEDICAL 2.665 € (+1,52 %)     SOFINA 218.000 € (+0,55 %)  
   74SOFTWARE 38.300 € (+1,86 %)     ALTAREA 96.400 € (-0,52 %)     LAURENT-PERRIER 88.400 € (0,00 %)     BE SEMICONDUCTOR 314.300 € (-0,85 %)     ATOS 36.240 € (+4,50 %)     SAINT GOBAIN 78.080 € (+3,06 %)     NEDAP 96.900 € (-0,92 %)     ASM INTERNATIONAL 1 025.000 € (+0,99 %)     SAFRAN 316.400 € (+3,36 %)     IMCD 88.820 € (+0,23 %)     PHILIPS KON 23.080 € (+1,18 %)     AKZO NOBEL 58.900 € (+1,94 %)     ING GROEP N.V. 26.325 € (+1,41 %)     AHOLD DEL 36.010 € (-0,99 %)     PROSUS 39.570 € (+0,70 %)     INPOST 15.290 € (-0,20 %)     PUBLICIS GROUPE SA 89.820 € (+0,18 %)     CVC CAPITAL 13.260 € (+2,39 %)     EUROFINS SCIENT. 63.380 € (-1,09 %)     BNP PARIBAS ACT.A 98.650 € (+2,03 %)     NN GROUP 73.660 € (+0,52 %)     COVIVIO 55.200 € (+0,27 %)     AALBERTS NV 40.440 € (+0,85 %)     AXA 41.880 € (+2,50 %)     SOCIETE GENERALE 76.000 € (+3,54 %)     DBV TECHNOLOGIES 3.188 € (+5,77 %)     CROSSJECT 1.926 € (-0,31 %)     WOLTERS KLUWER 60.240 € (-1,41 %)     ADYEN 858.900 € (+3,68 %)     ABN AMRO BANK N.V. 35.280 € (+1,76 %)     CREDIT AGRICOLE 16.930 € (+1,23 %)     WENDEL 85.450 € (+1,67 %)     SPIE 49.900 € (+1,96 %)     EURONEXT 148.300 € (+0,07 %)     ASML HOLDING 1 622.200 € (-0,45 %)     UNILEVER 50.580 € (-0,43 %)     ARCELORMITTAL SA 59.920 € (-1,12 %)     UMG 17.945 € (+1,04 %)     CEGEDIM 11.320 € (+0,53 %)     STMICROELECTRONICS 68.450 € (+1,03 %)     BOUYGUES 50.680 € (+0,76 %)     NICOX 0.370 € (+6,78 %)     CSG 13.910 € (-3,99 %)     ENGIE 27.300 € (-0,76 %)     SHELL PLC 35.680 € (-4,37 %)     STELLANTIS NV 6.091 € (+3,24 %)     BUREAU VERITAS 26.120 € (+2,59 %)     QWAMPLIFY 1.800 € (-9,55 %)     SAFE 0.570 € (-8,06 %)     FREELANCE.COM 2.810 € (+0,36 %)     BURELLE 411.000 € (+1,48 %)     TOTALENERGIES 73.000 € (-4,43 %)     DERICHEBOURG 10.200 € (-0,49 %)     ACCOR 48.780 € (+2,93 %)     VALEO 14.855 € (+2,24 %)     BRUNEL INTERNAT 7.160 € (-0,83 %)     2CRSI 50.150 € (+0,46 %)     MERSEN 44.600 € (+1,69 %)     L'OREAL 385.850 € (-1,13 %)     VERALLIA 19.570 € (-2,83 %)  
News Réglementées
03/01/2023 14:36

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

The Vanguard Group, Inc. ( )
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

03-Jan-2023 / 13:36 GMT/BST
Dissemination of a Regulatory Announcement, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.


FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

 

1. KEY INFORMATION

 

(a) Full name of discloser:

The Vanguard Group, Inc.

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

 The naming of nominee or vehicle companies is insufficient.  For a trust, the trustee(s), settlor and beneficiaries must be named.

 

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

 Use a separate form for each offeror/offeree

Mediclinic International plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

 

(e) Date position held/dealing undertaken:

 For an opening position disclosure, state the latest practicable date prior to the disclosure

29 December 2022

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

 If it is a cash offer or possible cash offer, state “N/A”

N/A

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

10p ordinary

 

 

 

 

Interests

Short positions

 

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

18,016,212

2.44%

 

 

(2) Cash-settled derivatives:

 

 

 

 

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

 

 

 TOTAL:

18,016,212

2.44%

 

 

 

 

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors’ and other employee options)

 

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

10p ordinary

Purchase

2,538

4.98 GBP

 

 (b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

 

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

 

 

 

 

 

 

 

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included.  If there are no such agreements, arrangements or understandings, state “none”

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

 

 

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

03 January 2023

Contact name:

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière